Enlivex Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.04 (-3.67%)

As of Mar 29, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +3,400.0% upside

Low Target $26.33

Average Target $36.75

High Target $40.94

Current Price $1.05

Current
$1.05

Target
$36.75

$26.33 $36.75 avg $40.94

Scenario Analysis

Bear Case

$26.33

2,407.6%

Low target

Base Case

$36.75

+3,400.0%

Avg target

Bull Case

$40.94

+3,799.0%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$2.10

-50.0% from high

52-Week Low

$0.66

+59.1% from low

Target vs 52W High

$36.75

+1,650.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%